Details
| Stereochemistry | ABSOLUTE |
| Molecular Formula | C6H15O15P3 |
| Molecular Weight | 420.0956 |
| Optical Activity | UNSPECIFIED |
| Defined Stereocenters | 6 / 6 |
| E/Z Centers | 0 |
| Charge | 0 |
SHOW SMILES / InChI
SMILES
O[C@H]1[C@H](O)[C@@H](OP(O)(O)=O)[C@H](OP(O)(O)=O)[C@H](OP(O)(O)=O)[C@@H]1O
InChI
InChIKey=GKDKOMAJZATYAY-UOTPTPDRSA-N
InChI=1S/C6H15O15P3/c7-1-2(8)4(19-22(10,11)12)6(21-24(16,17)18)5(3(1)9)20-23(13,14)15/h1-9H,(H2,10,11,12)(H2,13,14,15)(H2,16,17,18)/t1-,2-,3+,4-,5-,6-/m1/s1
Atrinositol antagonizes the effect of neuropeptide Y (NPY) in guinea pig basilar arteries. Atrinositol molecule derived from phytic acid. It seems to exert potent protective effects on some of the manifestations associated with diabetes in rats. Atrinositol inhibits glucose-stimulated insulin secretion by a direct effect on the pancreatic islets. Atrinositol appears to modulate fatty acid desaturases and aldose reductase in platelets and delay by a few weeks the development of cataract in this acute model of diabetes. It normalizes platelet aggregation in diabetic animals after long-term administration in vivo.
Approval Year
| Name | Type | Language | ||
|---|---|---|---|---|
|
Official Name | English | ||
|
Common Name | English | ||
|
Code | English | ||
|
Common Name | English | ||
|
Code | English | ||
|
Common Name | English |
| Classification Tree | Code System | Code | ||
|---|---|---|---|---|
|
NCI_THESAURUS |
C1327
Created by
admin on Fri Dec 15 15:40:15 GMT 2023 , Edited by admin on Fri Dec 15 15:40:15 GMT 2023
|
||
|
NCI_THESAURUS |
C257
Created by
admin on Fri Dec 15 15:40:15 GMT 2023 , Edited by admin on Fri Dec 15 15:40:15 GMT 2023
|
| Code System | Code | Type | Description | ||
|---|---|---|---|---|---|
|
DTXSID701317926
Created by
admin on Fri Dec 15 15:40:15 GMT 2023 , Edited by admin on Fri Dec 15 15:40:15 GMT 2023
|
PRIMARY | |||
|
CHEMBL2106016
Created by
admin on Fri Dec 15 15:40:15 GMT 2023 , Edited by admin on Fri Dec 15 15:40:15 GMT 2023
|
PRIMARY | |||
|
65762
Created by
admin on Fri Dec 15 15:40:15 GMT 2023 , Edited by admin on Fri Dec 15 15:40:15 GMT 2023
|
PRIMARY | |||
|
VYF3049W3N
Created by
admin on Fri Dec 15 15:40:15 GMT 2023 , Edited by admin on Fri Dec 15 15:40:15 GMT 2023
|
PRIMARY | |||
|
SUB05606MIG
Created by
admin on Fri Dec 15 15:40:15 GMT 2023 , Edited by admin on Fri Dec 15 15:40:15 GMT 2023
|
PRIMARY | |||
|
100000086657
Created by
admin on Fri Dec 15 15:40:15 GMT 2023 , Edited by admin on Fri Dec 15 15:40:15 GMT 2023
|
PRIMARY | |||
|
28841-62-5
Created by
admin on Fri Dec 15 15:40:15 GMT 2023 , Edited by admin on Fri Dec 15 15:40:15 GMT 2023
|
PRIMARY | |||
|
6844
Created by
admin on Fri Dec 15 15:40:15 GMT 2023 , Edited by admin on Fri Dec 15 15:40:15 GMT 2023
|
PRIMARY | |||
|
C74334
Created by
admin on Fri Dec 15 15:40:15 GMT 2023 , Edited by admin on Fri Dec 15 15:40:15 GMT 2023
|
PRIMARY | |||
|
C059368
Created by
admin on Fri Dec 15 15:40:15 GMT 2023 , Edited by admin on Fri Dec 15 15:40:15 GMT 2023
|
PRIMARY |
ACTIVE MOIETY
SALT/SOLVATE (PARENT)
